The role of carcinoembryonic antigen monitoring in management of colorectal cancer

Carcinoembryonic antigen (CEA) is an important tool in the management of colorectal cancer. Its use as a prognostic indicator in resectable disease remains controversial but may be improved with molecular detection of the antigen. In monitoring patients after resection, CEA can be the first sign of...

Full description

Saved in:
Bibliographic Details
Published in:Current oncology reports 1999, Vol.1 (2), p.168-172
Main Authors: Mulcahy, M F, Benson, 3rd, A B
Format: Article
Language:English
Subjects:
Biomarkers, Tumor - blood
Carcinoembryonic Antigen - blood
Colorectal Neoplasms - diagnosis
Colorectal Neoplasms - prevention & control
Colorectal Neoplasms - therapy
Guidelines as Topic
Humans
Mass Screening - methods
Perioperative Care
Prognosis
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c212t-e919de69077a4bce57b671d30dce2f67aa97bd82e4496e4c28b0abf0729abb353
cites cdi_FETCH-LOGICAL-c212t-e919de69077a4bce57b671d30dce2f67aa97bd82e4496e4c28b0abf0729abb353
container_end_page 172
container_issue 2
container_start_page 168
container_title Current oncology reports
container_volume 1
creator Mulcahy, M F
Benson, 3rd, A B
description Carcinoembryonic antigen (CEA) is an important tool in the management of colorectal cancer. Its use as a prognostic indicator in resectable disease remains controversial but may be improved with molecular detection of the antigen. In monitoring patients after resection, CEA can be the first sign of a potentially curable recurrence. It can also be useful in assessing tumor response in patients being treated for metastases without easily measurable disease. CEA alone cannot dictate the type or duration of treatment but may be used in addition to standard monitoring tests.
doi_str_mv 10.1007/s11912-999-0029-z
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_69507221</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>69507221</sourcerecordid><originalsourceid>FETCH-LOGICAL-c212t-e919de69077a4bce57b671d30dce2f67aa97bd82e4496e4c28b0abf0729abb353</originalsourceid><addsrcrecordid>eNpFkE1LAzEURYMotlZ_gBuZlbtoXuYjk6UUq0JBkLoOSeZNHZlJajJdtL_e1BZcvXfh3Ls4hNwCewDGxGMEkMCplJIyxiXdn5EplHlBK17J88PPc5oLySbkKsbvxDBWs0syAQDOayin5GP1hVnwPWa-zawOtnMeBxN23nU2027s1uiyIaXRh86tsy4l7fQaB3TjX8n3PqAddZ_6zmK4Jhet7iPenO6MfC6eV_NXunx_eZs_LanlwEeKEmSDlWRC6MJYLIWpBDQ5ayzythJaS2GammNRyAoLy2vDtGmZ4FIbk5f5jNwfdzfB_2wxjmroosW-1w79NqpKlgnmkEA4gjb4GAO2ahO6QYedAqYOItVRpEoi1UGk2qfO3Wl8awZs_hsnc_kvi6Jv_Q</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>69507221</pqid></control><display><type>article</type><title>The role of carcinoembryonic antigen monitoring in management of colorectal cancer</title><source>Springer Link</source><creator>Mulcahy, M F ; Benson, 3rd, A B</creator><creatorcontrib>Mulcahy, M F ; Benson, 3rd, A B</creatorcontrib><description>Carcinoembryonic antigen (CEA) is an important tool in the management of colorectal cancer. Its use as a prognostic indicator in resectable disease remains controversial but may be improved with molecular detection of the antigen. In monitoring patients after resection, CEA can be the first sign of a potentially curable recurrence. It can also be useful in assessing tumor response in patients being treated for metastases without easily measurable disease. CEA alone cannot dictate the type or duration of treatment but may be used in addition to standard monitoring tests.</description><identifier>ISSN: 1523-3790</identifier><identifier>EISSN: 1534-6269</identifier><identifier>DOI: 10.1007/s11912-999-0029-z</identifier><identifier>PMID: 11122815</identifier><language>eng</language><publisher>United States</publisher><subject>Biomarkers, Tumor - blood ; Carcinoembryonic Antigen - blood ; Colorectal Neoplasms - diagnosis ; Colorectal Neoplasms - prevention &amp; control ; Colorectal Neoplasms - therapy ; Guidelines as Topic ; Humans ; Mass Screening - methods ; Perioperative Care ; Prognosis</subject><ispartof>Current oncology reports, 1999, Vol.1 (2), p.168-172</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c212t-e919de69077a4bce57b671d30dce2f67aa97bd82e4496e4c28b0abf0729abb353</citedby><cites>FETCH-LOGICAL-c212t-e919de69077a4bce57b671d30dce2f67aa97bd82e4496e4c28b0abf0729abb353</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,4010,27902,27903,27904</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/11122815$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Mulcahy, M F</creatorcontrib><creatorcontrib>Benson, 3rd, A B</creatorcontrib><title>The role of carcinoembryonic antigen monitoring in management of colorectal cancer</title><title>Current oncology reports</title><addtitle>Curr Oncol Rep</addtitle><description>Carcinoembryonic antigen (CEA) is an important tool in the management of colorectal cancer. Its use as a prognostic indicator in resectable disease remains controversial but may be improved with molecular detection of the antigen. In monitoring patients after resection, CEA can be the first sign of a potentially curable recurrence. It can also be useful in assessing tumor response in patients being treated for metastases without easily measurable disease. CEA alone cannot dictate the type or duration of treatment but may be used in addition to standard monitoring tests.</description><subject>Biomarkers, Tumor - blood</subject><subject>Carcinoembryonic Antigen - blood</subject><subject>Colorectal Neoplasms - diagnosis</subject><subject>Colorectal Neoplasms - prevention &amp; control</subject><subject>Colorectal Neoplasms - therapy</subject><subject>Guidelines as Topic</subject><subject>Humans</subject><subject>Mass Screening - methods</subject><subject>Perioperative Care</subject><subject>Prognosis</subject><issn>1523-3790</issn><issn>1534-6269</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1999</creationdate><recordtype>article</recordtype><recordid>eNpFkE1LAzEURYMotlZ_gBuZlbtoXuYjk6UUq0JBkLoOSeZNHZlJajJdtL_e1BZcvXfh3Ls4hNwCewDGxGMEkMCplJIyxiXdn5EplHlBK17J88PPc5oLySbkKsbvxDBWs0syAQDOayin5GP1hVnwPWa-zawOtnMeBxN23nU2027s1uiyIaXRh86tsy4l7fQaB3TjX8n3PqAddZ_6zmK4Jhet7iPenO6MfC6eV_NXunx_eZs_LanlwEeKEmSDlWRC6MJYLIWpBDQ5ayzythJaS2GammNRyAoLy2vDtGmZ4FIbk5f5jNwfdzfB_2wxjmroosW-1w79NqpKlgnmkEA4gjb4GAO2ahO6QYedAqYOItVRpEoi1UGk2qfO3Wl8awZs_hsnc_kvi6Jv_Q</recordid><startdate>1999</startdate><enddate>1999</enddate><creator>Mulcahy, M F</creator><creator>Benson, 3rd, A B</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>1999</creationdate><title>The role of carcinoembryonic antigen monitoring in management of colorectal cancer</title><author>Mulcahy, M F ; Benson, 3rd, A B</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c212t-e919de69077a4bce57b671d30dce2f67aa97bd82e4496e4c28b0abf0729abb353</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1999</creationdate><topic>Biomarkers, Tumor - blood</topic><topic>Carcinoembryonic Antigen - blood</topic><topic>Colorectal Neoplasms - diagnosis</topic><topic>Colorectal Neoplasms - prevention &amp; control</topic><topic>Colorectal Neoplasms - therapy</topic><topic>Guidelines as Topic</topic><topic>Humans</topic><topic>Mass Screening - methods</topic><topic>Perioperative Care</topic><topic>Prognosis</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Mulcahy, M F</creatorcontrib><creatorcontrib>Benson, 3rd, A B</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Current oncology reports</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Mulcahy, M F</au><au>Benson, 3rd, A B</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The role of carcinoembryonic antigen monitoring in management of colorectal cancer</atitle><jtitle>Current oncology reports</jtitle><addtitle>Curr Oncol Rep</addtitle><date>1999</date><risdate>1999</risdate><volume>1</volume><issue>2</issue><spage>168</spage><epage>172</epage><pages>168-172</pages><issn>1523-3790</issn><eissn>1534-6269</eissn><abstract>Carcinoembryonic antigen (CEA) is an important tool in the management of colorectal cancer. Its use as a prognostic indicator in resectable disease remains controversial but may be improved with molecular detection of the antigen. In monitoring patients after resection, CEA can be the first sign of a potentially curable recurrence. It can also be useful in assessing tumor response in patients being treated for metastases without easily measurable disease. CEA alone cannot dictate the type or duration of treatment but may be used in addition to standard monitoring tests.</abstract><cop>United States</cop><pmid>11122815</pmid><doi>10.1007/s11912-999-0029-z</doi><tpages>5</tpages></addata></record>
fulltext fulltext
identifier ISSN: 1523-3790
ispartof Current oncology reports, 1999, Vol.1 (2), p.168-172
issn 1523-3790
1534-6269
language eng
recordid cdi_proquest_miscellaneous_69507221
source Springer Link
subjects Biomarkers, Tumor - blood
Carcinoembryonic Antigen - blood
Colorectal Neoplasms - diagnosis
Colorectal Neoplasms - prevention & control
Colorectal Neoplasms - therapy
Guidelines as Topic
Humans
Mass Screening - methods
Perioperative Care
Prognosis
title The role of carcinoembryonic antigen monitoring in management of colorectal cancer
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-27T15%3A19%3A07IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20role%20of%20carcinoembryonic%20antigen%20monitoring%20in%20management%20of%20colorectal%20cancer&rft.jtitle=Current%20oncology%20reports&rft.au=Mulcahy,%20M%20F&rft.date=1999&rft.volume=1&rft.issue=2&rft.spage=168&rft.epage=172&rft.pages=168-172&rft.issn=1523-3790&rft.eissn=1534-6269&rft_id=info:doi/10.1007/s11912-999-0029-z&rft_dat=%3Cproquest_cross%3E69507221%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c212t-e919de69077a4bce57b671d30dce2f67aa97bd82e4496e4c28b0abf0729abb353%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=69507221&rft_id=info:pmid/11122815&rfr_iscdi=true